Goodwill and Other Intangible Assets, Net (Tables)

6 Months Ended

Jun. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Movements in Goodwill

Movements in goodwill attributable to each reportable segment for the six months ended June 30, 2023 were as follows:

(DOLLARS IN MILLIONS)	Nourish		Health & Biosciences		Scent		Pharma Solutions		Total
Balance at December 31, 2022	$	6,050	$	4,321	$	1,745	$	1,239	$	13,355
Reduction from business divestitures	(4)		—		—		—		(4)
Foreign exchange	56		59		13		19		147
Balance at June 30, 2023	$	6,102	$	4,380	$	1,758	$	1,258	$	13,498

The goodwill balances at June 30, 2023 and December 31, 2022 include $2.250 billion of accumulated impairment related to the Health & Biosciences reportable segment. The accumulated impairment relates entirely to an impairment charge recorded in 2022.

Schedule of Other Intangible Assets, Net

Other intangible assets, net consisted of the following amounts:

	June 30,		December 31,
(DOLLARS IN MILLIONS)	2023		2022
Asset Type
Customer relationships	$	8,375	$	8,318
Technological know-how	2,359		2,339
Trade names & patents	360		358
Other	50		47
Total carrying value	11,144		11,062
Accumulated Amortization
Customer relationships	(1,470)		(1,252)
Technological know-how	(704)		(589)
Trade names & patents	(113)		(97)
Other	(44)		(42)
Total accumulated amortization	(2,331)		(1,980)
Other intangible assets, net	$	8,813	$	9,082

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Amortization expense for the next five years is expected to be as follows:

(DOLLARS IN MILLIONS)	2023		2024		2025		2026		2027
Estimated future intangible amortization expense	$	351	$	702	$	700	$	697	$	598